Clinical features of inflammatory bowel disease unclassified: a case-control study

被引:1
|
作者
Shao, Yupei [1 ]
Zhao, Yixiao [2 ]
Lv, Hong [1 ]
Yan, Pengguang [1 ]
Yang, Hong [1 ]
Li, Jingnan [1 ]
Li, Ji [1 ]
Qian, Jiaming [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gastroenterol, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China
[2] Civil Aviat Gen Hosp, Dept Gastroenterol, Beijing 100025, Peoples R China
关键词
Inflammatory bowel disease; Inflammatory bowel disease unclassified; Indeterminate colitis; Clinical features; Prognosis; POUCH-ANAL ANASTOMOSIS; INDETERMINATE COLITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; RETROSPECTIVE MULTICENTER; DIFFERENTIATION; DIAGNOSIS; GRANULOMA; CONSENSUS; SPECTRUM;
D O I
10.1186/s12876-024-03171-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundApproximately 10-15% of inflammatory bowel disease (IBD) patients with overlapping features of ulcerative colitis (UC) and Crohn's disease (CD) are termed as inflammatory bowel disease unclassified (IBDU). This study aimed to describe the clinical features of IBDU and evaluate the potential associated factors of reclassification.MethodsThe clinical data of 37 IBDU patients were retrospectively analyzed from November 2012 to November 2020. 74 UC and 74 CD patients were randomly selected and age- and sex-matched with the 37 IBDU patients. Clinical characteristics were compared between the three patient groups. Potential factors associated with the IBDU reclassification were evaluated.Results60% of IBDU patients displayed rectal-sparing disease, and 70% of them displayed segmental disease. In comparison to UC and CD, the IBDU group demonstrated higher rates of gastrointestinal bleeding (32.4%), intestinal perforation (13.5%), spontaneous blood on endoscopy (51.4%), and progression (56.8%). The inflammation proceeded relatively slowly, manifesting as chronic alterations like pseudopolyps (78.4%) and haustra blunt or disappearance (56.8%). 60% of IBDU patients exhibited crypt abscess, and 16.7% of them exhibited fissuring ulcers or transmural lymphoid inflammation. The proportions of IBDU patients receiving immunosuppressants, surgery, and infliximab were basically the same as those of CD patients. During the 79 (66, 91) months of follow-up, 24.3% of IBDU patients were reclassified as UC, while 21.6% were reclassified as CD. The presence of intestinal hemorrhaging was associated with CD reclassification, while hypoalbuminemia was associated with UC reclassification.ConclusionsIBDU may evolve into UC or CD during follow-up, and hemorrhage was associated with CD reclassification. Different from the other two groups, IBDU exhibited a more acute onset and a gradual progression. When an IBD patient presents with transmural inflammation or crypt abscess but lacks transmural lymphoid aggregates or fissuring ulcers, the diagnosis of IBDU should be considered.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Appendicectomy, tonsillectomy, and inflammatory bowel disease: a case-control record linkage study
    Kurina, LM
    Goldacre, MJ
    Yeates, D
    Seagroatt, V
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2002, 56 (07) : 551 - 554
  • [42] Use of contraceptives and risk of inflammatory bowel disease: A nested case-control study
    Pasvol, Thomas Joshua
    Bloom, Stuart
    Segal, Anthony Walter
    Rait, Greta
    Horsfall, Laura
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (03) : 318 - 326
  • [43] INFLAMMATORY BOWEL-DISEASE AND TOBACCO-SMOKE - A CASE-CONTROL STUDY
    PERSSON, PG
    AHLBOM, A
    HELLERS, G
    [J]. GUT, 1990, 31 (12) : 1377 - 1381
  • [44] Risk Factors for Lymphoma in Patients With Inflammatory Bowel Disease: A Case-Control Study
    Afif, Waqqas
    Sandborn, William J.
    Faubion, William A.
    Rahman, Meher
    Harmsen, William S.
    Zinsmeister, Alan R.
    Loftus, Edward V.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S42 - S42
  • [45] Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: A case-control study
    Felder, JB
    Korelitz, BI
    Rajapakse, R
    Schwarz, S
    Horatagis, AP
    Gleim, G
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (08): : 1949 - 1954
  • [46] Dietary risk factors for inflammatory bowel disease in Shanghai: A case-control study
    Mi, Lin
    Zhang, Chen
    Yu, Xiao-feng
    Zou, Jian
    Yu, Yang
    Bao, Zhi-Jun
    [J]. ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2022, 31 (03) : 405 - 414
  • [47] Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study
    Giuseppe Losurdo
    Rosa Federica La Fortezza
    Andrea Iannone
    Antonella Contaldo
    Michele Barone
    Enzo Ierardi
    Alfredo Di Leo
    Mariabeatrice Principi
    [J]. World Journal of Gastroenterology, 2020, (47) : 7528 - 7537
  • [48] Probiotic and Prebiotic Use in Patients with Inflammatory Bowel Disease: A Case-Control Study
    Hedin, Charlotte R. H.
    Mullard, Miriam
    Sharratt, Elizabeth
    Jansen, Clare
    Sanderson, Jeremy D.
    Shirlaw, Penelope
    Howe, Leslie C.
    Djemal, Serpil
    Stagg, Andrew J.
    Lindsay, James O.
    Whelan, Kevin
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (12) : 2099 - 2108
  • [49] Prevalence of appendectomy and tonsillectomy in patients with inflammatory bowel disease: a case-control study
    Erzin, Yusuf
    Telaku, Skender
    Yirmibescik, Sibel
    Celik, Aykut Ferhat
    Dirican, Ahmet
    Uzunismail, Huelya
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2008, 19 (03): : 199 - 200
  • [50] SMOKING-HABITS IN INFLAMMATORY BOWEL-DISEASE - A CASE-CONTROL STUDY
    LASHNER, BA
    SILVERSTEIN, MD
    EVANS, AA
    KIRSNER, JB
    HANAUER, SB
    [J]. GASTROENTEROLOGY, 1985, 88 (05) : 1465 - 1465